Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
LaNova Medicines Gets NMPA Approval for LM-305 Clinical Study
January 31, 2025
Company
Drug
Everest Medicines’ Nefecon NDA Accepted for IgA Nephropathy in China
January 31, 2025
Company
CStone Pharmaceuticals Suspends Suzhou Plant Operations to Cut Costs
January 31, 2025
Company
Medical Device
Hotgen Receives NMPA Approval for HBV RNA Assay Kit
January 31, 2025
Company
Drug
Innovent Biologics Initiates Phase III Trial for Mazdutide in Obesity
January 31, 2025
Company
Drug
Guangdong Zhongsheng Starts Phase III Trial for COVID-19 Drug RAY1216
January 31, 2025
Company
Drug
Yabao Receives FDA Clearance for Generic Nexavar
January 31, 2025
Company
Deals
Hansoh Pharmaceutical Licenses Biotheus’ Bispecific Antibody PM1080 for Greater China
January 31, 2025
Company
Deals
Sansure Biotech Partners with UBC to Manufacture in Indonesia
January 31, 2025
Company
HutchMed Shifts Focus to Late-Stage Pipeline for Regulatory Approvals
January 31, 2025
Company
Deals
Harbour BioMed and WuXi Biologics Announce Strategic Collaboration
January 31, 2025
Company
Drug
Hengrui’s Pyrotinib Granted Priority Review for HER2-Positive Breast Cancer
January 31, 2025
1
2
…
1,097
1,098
1,099
1,100
1,101
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
